MedTrace Logo

Spectral CT With Advanced CT Technology

NCT04781296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-04

No results posted yet for this study

Summary

The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.

Conditions

  • CT Photon-Counting

Interventions

DEVICE

CT with a photon-counting detector

Enrolled subjects will complete an exam using the photon-counting CT, with or without IV contract as indicated. Images will then be compared with the previously acquired CT conducted as standard of care.

Sponsors & Collaborators

  • Prismatic Sensors AB

    collaborator UNKNOWN

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Melissa Challman · GE Healthcare

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2022-12-14
Completion
2022-12-14

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04781296 on ClinicalTrials.gov